The acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2FDTQR8
via IFTTT
General Atlantic to acquire Rubicon as Everstone Cap exits
The acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2FDTQR8
via IFTTT
0 comments:
Post a Comment